Fig. 1From: The impact of policy interventions to promote the uptake of biosimilar medicines in Belgium: a nationwide interrupted time series analysisMonthly DDD evolution of etanercept (L04AB01) biosimilars over time, between March 2017 and August 2021Back to article page